News

< Back

Partner News: XPRIZE Healthspan Announces 10 Finalist Teams Receive $1 Million Milestone Awards Advancing Healthy Aging Research

Partner News: XPRIZE Healthspan Announces 10 Finalist Teams Receive $1 Million Milestone Awards Advancing Healthy Aging Research

On August 11th, 2026, XPRIZE announced 20 Finalist Teams advancing in the $101 million XPRIZE Healthspan competition, including 10 teams receiving $1 million Milestone 2 Awards to advance the development and clinical testing of potential therapies to improve healthspan.

Several AFAR board members have helped guide this important program.  AFAR’s Scientific Director Steven N. Austad, PhD, President Thomas Rando, MD, PhD, and Board Member Nir Barzilai, MD, serve as Scientific Advisors to XPRIZE Healthspan. AFAR Board Member Sergey Young is a sponsor of the competition. 

Additionally, AFAR Grantee and the 2022 winner of the Vincent Cristofalo Rising Star Award in Aging Research, Jamie L. Justice, PhD, is the Executive Vice President of the Health Domain at XPRIZE Foundation and Executive Director of XPRIZE Healthspan.

AFAR is a partner of the XPRIZE Healthspan and manages the XPRIZE Healthspan Longitudinal Data Analysis of Existing Cohorts Awards program, which supports distinct data analyses projects on select cohorts for a data resource network.

Read more on the XPRIZE Healthspan prize here.

More Recent News

View All News >
AFAR Experts in the News: Scientific Director Steven N. Austad, PhD, and Irving Wright Award Recipient S. Jay Olshansky, PhD on a new Blue Zone in Sardinia -–and its cues to Women’s Longevity--featured in Frontiers in Aging and National Geographic.
AFAR Experts in the News: Scientific Director Steven N. Austad, PhD, and Irving Wright Award Recipient S. Jay Olshansky, PhD on a new Blue Zone in Sardinia -–and its cues to Women’s Longevity--featured in Frontiers in Aging and National Geographic.
AFAR Experts in the News: New paper co-authored by Scientific Director Steven N. Austad, PhD, and Grantees Matt Kaeberlein, PhD, and Richard A. Miller, MD, PhD, published in Frontiers in Science explores potential aging rate indicators
AFAR Experts in the News: New paper co-authored by Scientific Director Steven N. Austad, PhD, and Grantees Matt Kaeberlein, PhD, and Richard A. Miller, MD, PhD, published in Frontiers in Science explores potential aging rate indicators
AFAR Grantee in the News: New research co-authored by Qinchuan Wang, PhD, on protein and age-related muscle dysfunction in Aging Cell.
AFAR Grantee in the News: New research co-authored by Qinchuan Wang, PhD, on protein and age-related muscle dysfunction in Aging Cell.
Board Member in the News: Nir Barzilai, MD, featured in National Geographic on the potential of GLP-1 drugs as gerotherapeutics.
Board Member in the News: Nir Barzilai, MD, featured in National Geographic on the potential of GLP-1 drugs as gerotherapeutics.
AFAR Experts in the News: Nature Aging publishes new research co-authored by multiple AFAR Grantees on the connection between the protein cyclin D1 in senescent cells and age-related diseases.
AFAR Experts in the News: Nature Aging publishes new research co-authored by multiple AFAR Grantees on the connection between the protein cyclin D1 in senescent cells and age-related diseases.
AFAR News: 45th Anniversary and 2025 Annual Report Out Now
AFAR News: 45th Anniversary and 2025 Annual Report Out Now
AFAR Grantee in the News: New research co-authored by Kristopher Burkewitz, PhD, on mitochondrial dysfunction and lifespan in Nature Communications.
AFAR Grantee in the News: New research co-authored by Kristopher Burkewitz, PhD, on mitochondrial dysfunction and lifespan in Nature Communications.
AFAR Experts in the News: TIME’s Longevity Leaders 2026 List spotlights Nir Barzilai, MD, Jamie L. Justice, PhD, and more.
AFAR Experts in the News: TIME’s Longevity Leaders 2026 List spotlights Nir Barzilai, MD, Jamie L. Justice, PhD, and more.
In Memoriam: AFAR Board Member Thomas G. Kahn, CFA
In Memoriam: AFAR Board Member Thomas G. Kahn, CFA